Studijní program
Předměty
Publikace
- Role of ABCB1, ABCG2, ABCC2 and ABCC5 transporters in placental passage of zidovudine2016 | Farmaceutická fakulta v Hradci Králové
- Effect of drug efflux transporters on placental transport of antiretroviral agent abacavir2015 | Farmaceutická fakulta v Hradci Králové
- Interactions of cyclin-dependent kinase inhibitors AT-7519, flavopiridol and SNS-032 with ABCB1, ABCG2 and ABCC1 transporters and their potential to overcome multidrug resistance in vitro2015 | Farmaceutická fakulta v Hradci Králové
- Interactions of tenofovir and tenofovir disoproxil fumarate with drug efflux transporters ABCB1, ABCG2, and ABCC2; role in transport across the placenta2014 | Farmaceutická fakulta v Hradci Králové
- Dabrafenib inhibits ABCG2 and cytochrome P450 isoenzymes; potential implications for combination anticancer therapy2022 | Farmaceutická fakulta v Hradci Králové
- ABCB1 as a potential beneficial target of midostaurin in acute myeloid leukemia2022 | Farmaceutická fakulta v Hradci Králové
- Targeting Pharmacokinetic Drug Resistance in Acute Myeloid Leukemia Cells with CDK4/6 Inhibitors2020 | Farmaceutická fakulta v Hradci Králové, Lékařská fakulta v Hradci Králové
- In vitro function and in situ localization of Multidrug Resistance-associated Protein (MRP)1 (ABCC1) suggest a protective role against methyl mercury-induced oxidative stress in the human placenta2020 | Farmaceutická fakulta v Hradci Králové
- Interplay of drug transporters P-glycoprotein (MDR1), MRP1, OATP1A2 and OATP1B3 in passage of maraviroc across human placenta2020 | Farmaceutická fakulta v Hradci Králové
- Cyclin-dependent kinase inhibitors AZD5438 and R547 show potential for enhancing efficacy of daunorubicin-based anticancer therapy: Interaction with carbonyl-reducing enzymes and ABC transporters2019 | Farmaceutická fakulta v Hradci Králové
Loading network view...